The National Birth Defects Prevention Study (NBDPS): Working together since 1997 to identify risk factors for birth defects

被引：0
|
作者：
Reefhuis, J. [1 ]
机构：
[1] CDC, NCBDDD, Atlanta, GA 30333 USA
来源：
BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY | 2008年 / 82卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：322 / 322
页数：1
相关论文
共 50 条
  • [31] Specific birth defects in pregnancies of women with diabetes: National Birth Defects Prevention Study, 1997-2011
    Tinker, Sarah C.
    Gilboa, Suzanne M.
    Moore, Cynthia A.
    Waller, D. Kim
    Simeone, Regina M.
    Kim, Shin Y.
    Jamieson, Denise J.
    Botto, Lorenzo D.
    Reefhuis, Jennita
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 222 (02)
  • [32] Use of benzodiazepine medications during pregnancy and potential risk for birth defects, National Birth Defects Prevention Study, 1997-2011
    Tinker, Sarah C.
    Reefhuis, Jennita
    Bitsko, Rebecca H.
    Gilboa, Suzanne M.
    Mitchell, Allen A.
    Tran, Emmy L.
    Werler, Martha M.
    Broussard, Cheryl S.
    BIRTH DEFECTS RESEARCH, 2019, 111 (10): : 613 - 620
  • [33] Risk of birth defects by pregestational type 1 or type 2 diabetes: National Birth Defects Prevention Study, 1997-2011
    Marchincin, Stephanie L.
    Howley, Meredith M.
    Van Zutphen, Alissa R.
    Fisher, Sarah C.
    Nestoridi, Eirini
    Tinker, Sarah C.
    Browne, Marilyn L.
    BIRTH DEFECTS RESEARCH, 2023, 115 (01): : 56 - 66
  • [34] Risk of Birth Defects by Pregestational Type 1 or Type 2 Diabetes: National Birth Defects Prevention Study, 1997-2011
    Marchincin, S. L.
    Howley, M. M.
    Van Zutphen, A. R.
    Fisher, S. C.
    Nestoridi, E.
    Tinker, S.
    Browne, M. L.
    BIRTH DEFECTS RESEARCH, 2021, 113 (10): : 778 - 778
  • [35] Maternal cyclobenzaprine exposure and risk of birth defects in the National Birth Defects Prevention Study (1997-2011) and Birth Defects Study to Evaluate Pregnancy exposureS (2014-2018)
    Fisher, Sarah M.
    Howley, Meredith L.
    Tran, Emmy C.
    Ailes, Elizabeth A.
    Papadopoulos, Eleni N.
    Nembhard, Wendy L.
    Browne, Marilyn
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 (08) : 855 - 862
  • [36] Maternal Cyclobenzaprine Exposure and Risk of Birth Defects in the National Birth Defects Prevention Study (1997-2011) and Birth Defects Study to Evaluate Pregnancy Exposures (2014-2018)
    Fisher, S. C.
    Howley, M. M.
    Tran, E. L.
    Ailes, E. C.
    Papadopoulos, E. A.
    Nembhard, W. N.
    Browne, M. L.
    BIRTH DEFECTS RESEARCH, 2022, 114 (09): : 392 - 392
  • [37] Maternal prepregnancy body mass index and congenital heart defects: Results from the National Birth Defects Prevention Study (NBDPS), 1997-2003
    Correa, A.
    Gilboa, S. M.
    Besser, L. M.
    Botto, L. D.
    Rasmussen, S. A.
    Waller, D. K.
    Cleves, M.
    Hobbs, C. A.
    Riehle-Colarusso, T.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2008, 167 (11) : S54 - S54
  • [38] The National Birth Defects Prevention Study
    Yoon, PW
    Rasmussen, SA
    Lynberg, MC
    Moore, CA
    Anderka, M
    Carmichael, SL
    Costa, P
    Druschel, C
    Hobbs, CA
    Romitti, PA
    Langlois, PH
    Edmonds, LD
    PUBLIC HEALTH REPORTS, 2001, 116 : 32 - 40
  • [39] Therapeutic opioid analgesic use before and during pregnancy, national birth defects prevention study (NBDPS), 1997-2003
    Broussard, C. S.
    Friedman, J. M.
    Rasmussen, S. A.
    Reefhuis, J.
    Jann, M. W.
    Honein, M. A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S161 - S161
  • [40] Prevalence of Urinary Tract Infections and Pharmacotherapy Use in Pregnancy - National Birth Defects Prevention Study (NBDPS), 1997-2007
    Gill, Simerpal K.
    Broussard, Cheryl
    Crider, Krista
    Berry, Robert J.
    Carter, Tonia
    Hobbs, Charlotte
    Reefhuis, Jennita
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 366 - 366
12345